FDA 510(k) Exemption for Unclassified Devices: New June 2026 Guidance

The US FDA has released a new final guidance, effective June 4, 2026, exempting certain unclassified medical devices from 510(k) premarket notification. This episode explains what 'unclassified devices' are, how this policy streamlines their market access pathway, and the specific actions manufacturers should take to leverage this change while remaining compliant with FDA's General Controls. Key Questions: - What are 'unclassified' medical devices under FDA regulations? - Which specific device types are now exempt from 510(k) submission as of June 2026? - How does this new guidance impact the market entry strategy for these products? - What are 'General Controls' and why do they still apply to 510(k)-exempt devices? - Does this exemption mean manufacturers no longer need a quality management system? - What are the immediate, practical steps regulatory affairs teams should take in response to this guidance? - How can this change accelerate timelines and reduce costs for product development? - Where can I find the official list of newly exempted devices? Sources: - https://www.fda.gov/medical-devices/news-events-medical-devices/cdrh-new-news-and-updates How Pure Global can help: Pure Global helps MedTech and IVD companies accelerate global market access. Our experts can help you interpret new FDA guidance, determine the regulatory status of your devices, and develop an efficient US market entry strategy. We use advanced AI tools to compile technical dossiers and manage submissions, ensuring compliance while reducing your time to market. Whether you're a startup or a multinational enterprise, our end-to-end solutions, including local representation and post-market surveillance, provide a streamlined path for your products. Contact us at [email protected], visit https://pureglobal.com, or explore our free AI tools and database at https://pureglobal.ai.